Nathalie Havet

Dr. Nathalie Havet

Université Claude Bernard, Lyon I, Lyon, Auvergne-Rhône-Alpes, France
orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2017 in International Archives of Occupational and Environmental Health
Verified
Journal Article
Closed access
PDF file
NHNathalie Havet
Nathalie Havet
APAlexis Penot
Alexis Penot
MMMagali Morelle
Magali Morelle
LPLionel Perrier
Lionel Perrier
BCBarbara Charbotel
Barbara Charbotel
BFBéatrice Fervers
Béatrice Fervers

1 June 2017 in International Journal of Medical Informatics
Verified
Journal Article
Closed access
MPMorgane Plantier
Morgane Plantier
NHNathalie Havet
Nathalie Havet
TDThierry Durand
Thierry Durand
NCNicolas Caquot
Nicolas Caquot
CACamille Amaz
Camille Amaz
LPLionel Perrier
Lionel Perrier

1 February 1999 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
ABArnaud Berger
Arnaud Berger
NHNathalie Havet
Nathalie Havet
DVDaniel Vial
Daniel Vial
LALaurence Arbibe
Laurence Arbibe
CDClaude Dumarey
Claude Dumarey
LTLhousseine Touqui
Lhousseine Touqui
We have recently shown that modified natural pulmonary surfactant Curosurf inhibits the synthesis of type II phospholipase A2 (sPLA2-II) by cultured guinea-pig alveolar macrophages (AM). The goal of the present study was to identify the surfactant components and the mechanisms involved in this process. We show that protein-free artificial surfactant (AS) mimicked the inhibitory effect of Curosurf, suggesting that phospholipid components of surfactant play a role in the inhibition of sPLA2-II expression. Among surfactant phospholipids, dioleylphosphatidylglycerol (DOPG) was the most effective in inhibiting the synthesis of sPLA2-II. By contrast, the concentrations of platelet-activating factor (PAF)–acetylhydrolase and lysophospholipase activities remained unchanged, indicating that inhibition of sPLA2-II synthesis was caused by a specific effect of surfactant. The effect of DOPG on sPLA2-II synthesis was concentration-dependent and was accompanied by a rapid and time-dependent uptake of DOPG by AM whereas dipalmitoylphosphatidylcholine (DPPC) was only marginally taken up. Curosurf, AS, and DOPG inhibited tumor necrosis factor-alpha (TNF- α ) secretion, a key step in the induction of sPLA2-II synthesis by AM, in contrast to DPPC which had only a marginal effect. We conclude that phospholipid components, especially DOPG, play a major role in the inhibition of sPLA2-II synthesis by surfactant and that this effect can be explained, at least in part, by an impairment of TNF- α secretion.

4 January 2018 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
MHMarius Huguet
Marius Huguet
LPLionel Perrier
Lionel Perrier
OBOlivia Bally
Olivia Bally
DBDavid Benayoun
David Benayoun
PHPierre De Saint Hilaire
Pierre De Saint Hilaire
IRIsabelle Ray-Coquard
Isabelle Ray-Coquard
To investigate the relationship between hospital volume activities and the survival for Epithelial Ovarian Carcinoma (EOC) patients in France. This retrospective study using prospectively implemented databases was conducted on an exhaustive cohort of 267 patients undergoing first-line therapy during 2012 in the Rhone-Alpes Region of France. We compared Progression-Free Survival for Epithelial Ovarian Carcinoma patients receiving first-line therapy in high- (i.e. ≥ 12 cases/year) vs. low-volume hospitals. To control for selection bias, multivariate analysis and propensity scores were used. An adjusted Kaplan-Meier estimator and a univariate Cox model weighted by the propensity score were applied. Patients treated in the low-volume hospitals had a probability of relapse (including death) that was almost two times (i.e. 1.94) higher than for patients treated in the high-volume hospitals (p < 0.001). To our knowledge, this is the first study conducted in this setting in France. As reported in other countries, there was a significant positive association between greater volume of hospital care for EOC and patient survival. Other factors may also be important such as the quality of the surgical resection.

1 October 2018 in Transportation Research Part A: Policy and Practice
Verified
Journal Article
Closed access
CBCaroline Bayart
Caroline Bayart
PBPatrick Bonnel
Patrick Bonnel
NHNathalie Havet
Nathalie Havet

1 November 2020 in Revue D'Épidémiologie Et de Santé Publique
Verified
Journal Article
Closed access
NHNathalie Havet
Nathalie Havet
JFJ. Fournier
J. Fournier
JSJ. Stefanelli
J. Stefanelli
MPM. Plantier
M. Plantier
APA. Penot
A. Penot